Home › Post-COVID Conditions (Long COVID) › Washington › Seattle
Post-COVID Conditions (Long COVID) clinical trials in Seattle, WA
4 studies for Post-COVID Conditions (Long COVID) are looking for participants at sites in and around Seattle (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
RecruitingPhase 3
- Seattle Rheumatology Associates, Seattle
- Swedish Ambulatory Infusion Center- First Hill, Seattle
- Swedish Cancer Institute Treatment Center, Seattle
- and 6 more
Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
RecruitingPhase 3
- Swedish Medical Center, Seattle
A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
RecruitingPhase 1
- GSK Investigational Site, Seattle
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
RecruitingPhase 3
- Seattle Children's Hospital, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Fred Hutchinson Cancer Research Center, Seattle
About Post-COVID Conditions (Long COVID)
Anyone who had COVID-19 can have ongoing symptoms. Learn about post-COVID conditions (long COVID), including symptoms, diagnosis, treatments, and prevention.
More about Post-COVID Conditions (Long COVID) on MedlinePlus
Post-COVID Conditions (Long COVID) trials in other cities
- New York City, NY15 studies
- Houston, TX13 studies
- Boston, MA13 studies
- Baltimore, MD12 studies
- Chicago, IL11 studies
- Washington, DC10 studies
- San Francisco, CA8 studies
- Atlanta, GA8 studies
- Durham, NC8 studies
- San Diego, CA7 studies
- Miami, FL6 studies
- Hialeah, FL6 studies
Other studies in Seattle
- Non-Small Cell Lung Cancer53 studies
- Cancer (all types)50 studies
- Prostate Cancer44 studies
- Breast Cancer40 studies
- Acute Myeloid Leukemia40 studies
- Metastatic Cancer39 studies
- Colorectal Cancer34 studies
- Lung Cancer33 studies
- Ovarian Cancer31 studies
- Multiple Myeloma22 studies
- Pancreatic Cancer22 studies
- Myelodysplastic Syndromes21 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.